Folate-Functionalized Mesoporous Hollow SnO<sub>2</sub> Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy

<table class="fixed-width table-group" id="tab1"><tr><td><table class="table"><colgroup><col style="width:4.55em"/><col style="width:5.71em"/><col style="width:4.82em"/><col style="width:5.28em"/></colgroup><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Samples</td><td class="align_center"><svg height="11.9479pt" id="M15" style="vertical-align:-3.181499pt" version="1.1" viewbox="-0.0498162 -8.7664 23.2516 11.9479" width="23.2516pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M409 504C401 567 396 607 392 642C354 654 312 665 266 665C137 665 60 583 60 487C60 374 161 325 225 290C300 250 355 215 355 141C355 68 311 21 235 21C131 21 86 122 71 183L41 176C48 128 61 42 68 21C78 16 93 8 118 0C142 -7 175 -15 216 -15C349 -15 438 69 438 174C438 287 344 333 265 374C186 414 138 449 138 522C138 576 172 631 249 631C336 631 363 562 380 499L409 504Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,6.162,3.132)"><path d="M384 354C435 370 515 408 515 502C515 549 494 593 459 616C426 639 384 650 308 650H45V618C127 613 130 606 130 524V127C130 45 125 38 37 33V0H262C342 0 409 12 461 40C521 73 558 124 558 192C558 295 481 336 384 352V354ZM217 365V556C217 587 221 597 229 604C238 611 261 615 288 615C382 615 421 558 421 490C421 406 374 365 266 365H217ZM217 327H264C384 327 457 284 457 183C457 80 383 38 301 38C235 38 217 55 217 127V327Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,11.576,3.132)"><path d="M522 166C507 123 488 90 472 71C449 44 419 38 347 38C296 38 261 38 242 51C223 63 217 85 217 132V315H311C398 315 406 310 419 239H453V433H419C406 365 401 358 311 358H217V580C217 609 219 612 251 612H331C400 612 427 604 440 584C453 561 463 541 472 498L506 502C501 558 497 627 497 650H43V618C122 610 130 609 130 520V128C130 46 121 40 30 32V0H521C529 30 552 128 557 162L522 166Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,16.854,3.132)"><path d="M601 496C596 555 591 627 591 675H567C551 656 544 650 516 650H120C91 650 79 651 64 675H41C38 619 34 555 29 492H63C75 537 83 566 96 582C110 604 128 612 207 612H272V126C272 46 264 38 170 33V0H464V33C368 38 359 48 359 126V612H430C502 612 520 605 535 582C547 566 556 541 567 492L601 496Z"></path></g></svg>(m<sup>2</sup>/g)</td><td class="align_center"><svg height="11.6836pt" id="M16" style="vertical-align:-3.29562pt" version="1.1" viewbox="-0.0498162 -8.38798 12.6209 11.6836" width="12.6209pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M687 650H462V622C543 612 549 605 530 547C498 447 422 252 372 126H370C302 298 229 492 204 563C188 607 191 615 262 622V650H17V622C77 616 93 608 122 534C180 389 262 172 329 -11H360C436 196 541 450 568 516C606 605 619 614 687 622V650Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,9.139,3.132)"><path d="M303 37L293 66C280 59 256 49 231 49S173 63 173 143V396H281C294 404 298 428 287 439H173V575L158 577L92 509V439H46L17 408L22 396H92V107C92 27 128 -12 192 -12C203 -12 218 -9 237 2L303 37Z"></path></g></svg>(ml/g)</td><td class="align_center"><svg height="13.0857pt" id="M17" style="vertical-align:-4.69772pt" version="1.1" viewbox="-0.0498162 -8.38798 25.8353 13.0857" width="25.8353pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M43 650V622C120 616 128 612 128 526V124C128 39 120 33 34 27V0H270C392 0 492 25 567 83C643 141 690 230 690 350C690 444 655 517 605 565C543 625 450 650 323 650H43ZM213 547C213 587 217 598 226 604C236 612 262 617 304 617C371 617 429 604 474 576C554 529 592 439 592 336C592 176 505 36 319 36C246 36 213 55 213 131V547Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,9.555,3.132)"><path d="M384 354C435 370 515 408 515 502C515 549 494 593 459 616C426 639 384 650 308 650H45V618C127 613 130 606 130 524V127C130 45 125 38 37 33V0H262C342 0 409 12 461 40C521 73 558 124 558 192C558 295 481 336 384 352V354ZM217 365V556C217 587 221 597 229 604C238 611 261 615 288 615C382 615 421 558 421 490C421 406 374 365 266 365H217ZM217 327H264C384 327 457 284 457 183C457 80 383 38 301 38C235 38 217 55 217 127V327Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,14.997,3.132)"><path d="M310 650H45V617C128 612 136 604 136 522V187C136 103 134 47 125 -1C114 -60 85 -105 26 -133L41 -166C69 -158 100 -141 135 -110C201 -52 223 22 223 154V522C223 603 231 612 310 617V650Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,18.073,3.132)"><path d="M738 650H471V617C551 612 559 606 559 524V368H218V524C218 606 227 612 305 617V650H38V617C123 612 131 606 131 524V126C131 44 124 38 41 33V0H310V33C226 38 218 44 218 126V321H559V126C559 44 551 38 463 33V0H737V33C654 38 646 44 646 126V524C646 606 654 612 738 617V650Z"></path></g></svg>(nm)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">SNF</td><td class="align_center">26.29</td><td class="align_center">0.08</td><td class="align_center">12.50</td></tr><tr><td class="align_left">SFNF</td><td class="align_center">20.49</td><td class="align_center">0.06</td><td class="align_center">11.44</td></tr><tr><td class="align_left">SNFP</td><td class="align_center">3.96</td><td class="align_center">0.02</td><td class="align_center">10.41</td></tr><tr><td class="align_left">SFNFP</td><td class="align_center">4.20</td><td class="align_center">0.03</td><td class="align_center">9.59</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Detailed properties of SNF, SNFP, and SFNFP obtained by BET method.</div>

BioMed Research International

tab1

Table 1

Table 1: Folate-Functionalized Mesoporous Hollow SnO<sub>2</sub> Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy 

Table 1 | Folate-Functionalized Mesoporous Hollow SnO2 Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy 